LEVOSIMENDAN SALA 2.5mg / ml concentrate for solution for infusion EFG medication leaflet

C01CX08 levosimendan • Cardiovascular system | Cardiac stimulants excluding cardiac glycosides | Other cardiac stimulants

Levosimendan is a medication used for the treatment of acute decompensated heart failure. It acts as a calcium sensitizer, improving myocardial contractility without increasing oxygen consumption.

The medication is administered intravenously, usually as an infusion, under the supervision of a specialist. The dose is adjusted based on the patient's response and tolerance.

Side effects may include low blood pressure, headaches, nausea, or cardiac arrhythmias. In rare cases, severe allergic reactions may occur.

Levosimendan is not recommended for patients with severe hypotension, severe renal or hepatic impairment, or hypersensitivity to this medication.

General data about LEVOSIMENDAN SALA 2.5mg / ml CONCENTRATE FOR SOLUTION FOR INFUSION EFG

Substance: levosimendan

Date of last drug list: 01-05-2026

Commercial code: W71343001

Concentration: 2.5mg / ml

Pharmaceutical form: concentrate for solution for infusion

Quantity: 1

Product type: generic

Price: 960.15 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: LABORATORIO REIG JOFRE, S.A. - SPANIA

Holder: BESMAX PHARMA SOLUTIONS S.R.L. - ROMANIA

Number: 16/2025/01

Shelf life: 2 years

Other substances similar to levosimendan